What Is eMAR? A Care Home Manager's Guide

This guide explains electronic medication administration records (eMAR) for care homes in England. It is general guidance on records and CQC expectations, not clinical or procurement advice, and it does not recommend or endorse any specific product. Decisions about medicines management systems should involve your dispensing pharmacy and your local medicines optimisation team. References to NICE guidance and legislation are current as of the last reviewed date above.

eMAR stands for electronic Medication Administration Record. It is a digital version of the paper MAR chart: instead of staff signing a printed sheet by hand, they record each medicine on a phone, tablet, or computer, usually with a prompt for due doses and an alert when one is missed. The system builds a timestamped audit trail automatically.

The question most managers actually have is not "what is eMAR" — it is "do we need it, and will CQC expect it?" The short answer: CQC does not require eMAR. A well-kept paper MAR chart is fully compliant. eMAR is a tool that makes certain failures harder to commit, not a regulatory obligation. This guide explains what it does, what the rules require either way, and how to decide.

What eMAR does that paper does not

A paper MAR chart and an eMAR system record the same thing — who got which medicine, when. The difference is in what the system does around the record:

• Prompts for due doses. The system shows staff what is due now, rather than relying on them to read across a printed grid.
• Flags gaps in real time. A missed dose triggers an alert during the shift, not at the next monthly audit. On paper, a blank slot is often discovered weeks later.
• Forces a reason for non-administration. Most systems will not let a dose be skipped without selecting a code and, for the relevant codes, a note.
• Timestamps every entry. The record shows exactly when each dose was given, which is harder to reconstruct from a paper round.
• Produces audit-ready reports. Administration rates, refusal patterns, and PRN usage can be pulled without hand-counting charts.

None of this is magic. eMAR reduces the most common medication finding — unexplained gaps — by making a blank slot harder to leave. It does not fix poor processes, untrained staff, or weak governance.

What CQC requires, on paper or screen

The regulations are technology-neutral. They set out what must be recorded and managed, not how.

Regulation 12(2)(g) of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 requires "the proper and safe management of medicines." It says nothing about the format of the record.

Regulation 17(2)(c) requires you to "maintain securely an accurate, complete and contemporaneous record in respect of each service user, including a record of the care and treatment provided." A paper chart and an eMAR record both satisfy this if they are accurate, complete, and contemporaneous.

The practice guidance — NICE SC1 (Managing medicines in care homes) — likewise sets expectations for record accuracy and review without mandating a digital system.

So the compliance question is never "paper or electronic." It is "is the record accurate, complete, contemporaneous, and secure?" Both formats can pass. Both can fail.

Where eMAR helps — and where it does not

eMAR earns its place when it removes a failure mode you keep hitting. It is worth weighing honestly.

It helps most when:

• Your monthly MAR audits keep finding gaps you cannot explain after the fact.
• You run more than one site or several units and cannot easily oversee medication rounds across them.
• Medicine rounds are rushed and staff turnover is high, so real-time prompting genuinely changes behaviour.
• You spend hours preparing medication evidence for inspections and reviews.

It helps less when:

• Your paper system is already tight, your gap rate is near zero, and your audits are clean. eMAR will not improve a process that is already working — it will just change its medium.
• Your homes have weak connectivity, or staff are not confident with devices, and the rollout would introduce new errors faster than it removes old ones.
• The cost displaces spending on staff training or pharmacist involvement that would do more for medication safety.

A common mistake is treating eMAR as a substitute for governance. The systems that go wrong are the ones bought to "fix medication" without addressing the staffing, training, and audit culture underneath. The technology changes nothing on its own.

A new digital record is still a record CQC will review

If you move to eMAR, the record is still subject to the same scrutiny as paper — and a few new questions:

• Access and security. Who can edit a record, and is there an audit trail of changes? Regulation 17 requires records to be held securely. An editable digital record with no change log is weaker than a pen entry.
• Offline behaviour. What happens to a round if the network drops? There must be a clear, tested fallback so doses are not lost.
• Data and continuity. If you change provider, or the provider fails, can you export your records? A medication record you cannot retrieve is not a complete record.
• Controlled drugs. Electronic systems do not remove the legal requirements for controlled drug registers and witnessed stock checks. Confirm how the system handles CDs, or keep the statutory register alongside it.

These are exactly the questions to ask any provider before committing — and they are the questions an inspector may ask after you have switched.

How to decide

Run this short test before you spend anything:

1. Measure your current gap rate. Audit a month of paper charts and count unexplained gaps. If it is near zero, eMAR is solving a problem you do not have.
2. Name the failure mode you are buying out. Gaps? Oversight across sites? Audit time? If you cannot name it, do not buy yet.
3. Check the foundations. Are staff trained and competency-assessed? Is your pharmacist involved in governance? eMAR amplifies a good system and exposes a weak one.
4. Pilot before committing. Run one unit or one floor for a month. Compare the gap rate and the time spent before and after.
5. Ask the four record questions above of any provider — security, offline, export, controlled drugs.

For the underlying medicines requirements that apply whichever format you use, see our guide to medication management in care homes, and our reference on MAR chart codes. For building medication checks into a routine rather than discovering problems at inspection, see running a care home audit.

---

Whether your medication records live on paper or on a screen, the real work is keeping them — and every other strand of evidence — organised and ready for CQC. InspectReady does exactly that for independent care homes, without the enterprise price tag. Start your free trial — 14 days free, no card required.